NCT02627690View on ClinicalTrials.gov

Nephrologic Prognosis 10 Years After Diabetes Cell Therapy

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

November 3, 2014

Primary Completion Date

November 29, 2021

Study Completion Date

November 29, 2021

Conditions
Islet Transplantation
Interventions
OTHER

islet transplanted

islet transplantation

OTHER

non islet transplanted

no islet transplantation (for a non nephrologic reason)

Trial Locations (1)

59037

Lille University Hospital, Lille

All Listed Sponsors
lead

University Hospital, Lille

OTHER

NCT02627690 - Nephrologic Prognosis 10 Years After Diabetes Cell Therapy | Biotech Hunter | Biotech Hunter